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v A case of prostatic carcinoma metastasis to the pituitary gland is reported. The presentation and rarity of 
such a lesion is addressed. The literature review yielded only isolated case reports of symptomatic brain 
metastases unassociated with bone disease from adenocarcinoma of the prostate. The management options of 
such a lesion are discussed. 
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I NTRACRANIAL metastasis from adenocarcinoma of the prostate is uncommon. Carcinoma of the pros-tate is the third leading cause of malignancy-related 
death in North American men. This malignancy has 
been found at autopsy in 70% of men over the age of 
80 years,8 and skeletal and pulmonary metastases pre-
dominate; intraparenchymal central nervous system 
metastases occur in only 0.6% to 4.4% of cases. 5.6 A 
case of prostate adenocarcinoma metastasis to the pi-
tuitary gland is presented. To our knowledge this is the 
first reported case of symptomatic pituitary metastasis 
unassociated with sellar osseous disease. 
Case Report 
This 61-year-old right-handed man presented with a 
2-month history of increasing bifrontal headache and 
peripheral visual loss. Ophthalmological evaluation re-
vealed a marked bitemporal hemianopsia; subsequent 
computerized tomography (CT) and magnetic reso-
nance imaging revealed a large sellar mass with supra-
sellar extension (Fig. I). He was referred for neurosur-
gical evaluation. His medical history was remarkable 
for a transurethral resection of the prostate performed 
2 years previously with reported benign pathology; the 
patient had no current urinary symptoms. 
Examination. Physical examination disclosed a 
dense bitemporal hemianopsia, and a preoperative chest 
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x-ray film revealed extensive blastic lesions of multiple 
ribs, vertebrae, and the right humerus. Preoperative 
endocrine evaluation was normal, but the acid phos-
phatase level was noted to be markedly elevated at 209 
Uiliter (normal 1 to 8 U/liter). A preoperative diagnosis 
of metastatic carcinoma of the prostate was made; the 
relationship of the pituitary lesion to the prostatic pri-
mary site was uncertain. In consideration of the rarity 
of intracranial prostatic metastasis, it was believed that 
a primary pituitary process was not precluded. 
Operation. In the face of a relentlessly progressive 
visual loss and the questionable pituitary pathology, the 
patient underwent urgent transsphenoidal craniotomy 
with resection of the sellar and suprasellar mass. Upon 
exposure of the sphenoid sinus and the sella, no evi-
dence of bone or dural involvement by tumor was 
noted. A firm, white, rubbery lesion was encountered 
within the parenchyma of the pituitary extending into 
the suprasellar cistern. A gross total resection was ac-
complished. Pathological examination revealed adeno-
carcinoma compatible with a prostatic primary tumor 
(Fig. 2). 
Postoperative Course. Postoperatively, the visual 
field defects improved markedly. The patient was dis-
charged on the 6th postoperative day following bilateral 
orchiectomy for his Stage D metastatic disease. He is 
alive and neurologically asymptomatic 18 months fol-
lowing operation. 
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FIG. 1. Preoperative magnetic resonance image demonstrat-
ing a large sellar mass with suprasellar extension. 
Discussion 
Classically, carcinoma of the prostate is associated 
with skeletal, pulmonary, and hepatic metastases.7 Cen-
tral nervous system involvement is most commonly 
secondary to epidural compression from overlying bone 
disease.9 There are several potential modes of metastatic 
tumor spread: direct extension, lymphatic seeding, and 
vascular embolization (arterial and venous). The exact 
route involved in cerebral metastasis is at present con-
troversial, and in fact may involve several mechanisms. 
The paravertebral venous plexus has previously been 
elegantly demonstrated as a plausible route of meta-
static spread of prostatic tumor. I During a Valsalva 
maneuver, blood flow is reversed from the inferior vena 
cava into the vertebral veins, and access is achieved to 
the skull base. In instances of transit through dural 
veins, subdural seeding is possible and contiguous 
spread through Virchow-Robin spaces allows intrace-
rebral metastases to occur. Varkarakis, et aI., 13 however. 
invoked a multistep cascade process in the genesis of 
cerebral metastases, whereby pulmonary and bone in-
volvement precede neural metastases. This has been 
advocated as the more common method of spread, 
supported clinically by the usual evidence of multiple-
system involvement at the time of presentation of 
symptomatic cerebral metastasis. A contradiction is the 
solitary brain metastasis in the absence of other organ 
involvement, as reported by Smith, et at. 12 
While cerebral metastases are notably uncommon in 
prostatic carcinoma, initial presentation with brain me-
tastasis is extremely rare. 56 I I The majority of these 
metastatic lesions are incidental findings at autopsy and 
are solitary;3 antemortem diagnosis varies from 25% to 
62.5% in different series. It is of interest that the average 
age of patients suffering from metastatic lesions to the 
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FIG. 2. Photomicrograph showing prostatic adenocarci-
noma infiltrating the pituitary. The glandular structures that 
are lined by large columnar cells with nuclei containing prom-
inent nucleoli contrast with the smaller pituitary cells with 
dark nuclei. H & E, x 70. 
cerebral parenchyma is younger than that of patients 
diagnosed with carcinoma of the prostate in general (59 
vs. 70 years). 10 The basis for this disparity is speculative 
but it may be the result of a more clinically aggressive 
tumor in patients with cerebral metastases, supported 
pathophysiologically by poorly differentiated tumors 
found histologically, as in this patient and in other case 
reports. 5. I I 
The literature usually reports a short period of sur-
vival in patients with brain metastases.4.5. 14 This is most 
likely a reflection of the extent of disease at the time of 
diagnosis; however, there are isolated reports of pro-
longed survival following surgical extirpation of the 
metastatic lesion. 10-12 External beam radiation therapy 
and hormonal manipulation may also prolong survival 
in selected patients.2lo The present case supports the 
general consensus that neurosurgical intervention may 
be of symptomatic benefit and may possibly prolong 
life in selected patients with carcinoma of the prostate. 
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